Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2400087781Phase 4Recruiting
Phase 4, randomised trial in postoperative pain and postoperative nausea and vomiting (PONV) comparing Compound betamethasone + ropivacaine ESPB with Ropivacaine alone ESPB (2 arms). Primary endpoints: Incidence of moderate to severe pain within 24 hours after surgery and Postoperative quality of recovery. Started Aug 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2400087781.